Clinical trials
Recruiting Ovarian Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Daiichi Sankyo | 2 |
| Gynaecologisch Oncologisch Centrum Zuid | 2 |
| ARCAGY/ GINECO GROUP | 1 |
| Amsterdam UMC, location VUmc | 1 |
| AstraZeneca | 1 |
| Fore Biotherapeutics | 1 |
| Incyte Corporation | 1 |
| M.D. Anderson Cancer Center | 1 |
| Maastricht University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 20 |
| Endometrial Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Fallopian Tube Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Uterine Cervical Neoplasms | 4 |
| Esophageal Neoplasms | 3 |
| Head and Neck Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Neoplasms | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.